Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has assisted in connection with Samhällsbyggnadsbolaget’s listing on Nasdaq Stockholm
Mandate

Vinge has assisted in connection with Samhällsbyggnadsbolaget’s listing on Nasdaq Stockholm

September 26, 2019 Capital Markets and Public M&A

Vinge has assisted with counselling on securities law and transaction execution in connection with Samhällsbyggnadsbolaget i Norden AB (publ)’s list change of their B‑ and D‑shares from Nasdaq First North Premier Growth Market to Nasdaq Stockholm’s main market.

The prospectus was published on 18 September 2019 and the trading on Nasdaq Stockholm commenced 20 September 2019.

The company’s strategy is to own, manage and develop community service properties throughout the Nordic region and rental apartments in growth regions in Sweden. As of 30 June 2019, the
property portfolio consisted of 790 properties with a reported amount for investment properties totalling SEK 30.3 billion.

Vinge’s team has primarily consisted of Jesper Schönbeck, Malte Hedlund, Boris Kotur, Anders Sundin Lundberg and Nils Fredrik Dehlin. Maria Schultzberg, Victor Ericsson and Henrik Wastenson advised on tax issues.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026